Navigation Links
Sentara begins international trial -- open at only 24 US locations
Date:9/25/2008

Norfolk, VA September 23, 2008 Researchers at Sentara Cardiovascular Research Institute begin a new international study to explore the safety and effectiveness of stents to open airways of patients with advanced emphysema or Chronic Obstructive Pulmonary Disease (COPD).

The EASE (Exhale Airway Stents for Emphysema) Trial focuses on airway bypass, an investigational technique without surgery to create new pathways to release trapped air from within diseased lung tissue, thereby helping patients with advanced widespread emphysema breathe easier.

Similar to the stents used to prop open clogged arteries in heart patients, these drug-eluting stents are now holding open new passageways in the lungs.

Pulmonologists and cardiothoracic surgeons at Sentara Thoracic Surgery Center in Norfolk, Virginia are collaborating to perform this investigational procedure of the first wave of Virginia participants. During the procedure, a tube is guided through the mouth of trial participants to access the lung and implant up to six stents smaller than a pencil eraser. The goal is to relieve breathlessness and over inflated lungs hallmarks of this incurable, progressive disease.

Traditional treatment options for patients with severe emphysema are limited to lung reduction surgery, lung transplant, and inhalers, which have diminishing impact as the disease progresses. Airway bypass, done without open surgery, is considered minimally invasive and hoped to be an option for broader numbers of patients.

"Emphysema is really life limiting. Some of my patients who golfed a year ago now get winded taking a shower," says cardiothoracic surgeon Joseph Newton, Sentara Cardiovascular Research Institute's principal investigator for this trial. "Through research like this, I'm hopeful we are going to find a way to help these patients do things most of us take for granted," he continues.

That's just what trial candidate John Woodard is hoping for. The 61-year-old Suffolk resident is being evaluated Tuesday, September 22 at Sentara to begin the enrollment process.

"I don't look sick," says Woodard. "You wouldn't know any better until you saw me exercise," continues Woodard who ran 35 miles each week up until about 10 years ago. Woodard retired a year ago because of his condition. "I still play golf, but I have to bring my oxygen with me," he says.

"Research like this gives new hope of a longer-term solution for more people. Transplant is not a practical option for a lot of people with severe emphysema," says Dr. Carolyn Fruci, pulmonologist and critical care specialist involved in the study. "What's exciting is the possibility of patients regaining some of the everyday freedoms lost to this disease," Fruci continues.

Transplant, one of the only treatments today for patients with severe emphysema, is not plausible for every patient. Participation in this trial does not prevent patients from being considered for lung transplantation at a later time.

For Woodard, who has been coping with COPD for the last 10 years, participating in this research offers hope. "I'm up for most anything. Naturally if there's any benefitto me or anybody elsethat would be wonderful," say Woodard, who is being evaluated for participation in the trial.


'/>"/>

Contact: Cheri Hinshelwood
CSHINSHE@sentara.com
757-594-1036
Broncus Technologies
Source:Eurekalert  

Related biology news :

1. Building a stronger roof over your head: 3 little pigs project begins first tests
2. 8-day undersea mission begins experiment to improve coral reef restoration
3. War between the sexes begins before twins birth, TAU researchers say
4. iPlant Kickoff Conference at CSHL begins tackling plant biologys grand challenges
5. Clinical trial that may help patients breathe easier begins at Central DuPage Hospital
6. DHS Begins Collecting 10 Fingerprints From International Visitors at New Yorks John F. Kennedy International Airport
7. DHS Begins Collecting 10 Fingerprints From International Visitors at Detroit Metropolitan Wayne County Airport
8. DHS Begins Collecting 10 Fingerprints From International Visitors at Orlando International Airport
9. DHS Begins Collecting 10 Fingerprints From International Visitors at Miami International Airport
10. DHS Begins Collecting 10 Fingerprints From International Visitors at San Francisco International Airport
11. DHS Begins Collecting 10 Fingerprints From International Visitors at George Bush Houston Intercontinental Airport
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sentara begins international trial -- open at only 24 US locations
(Date:8/21/2020)... ... , ... The 19th Annual Bio-IT World Conference & ... and IT leaders goes VIRTUAL and announces its updated event features and full ... the leadership role of keeping our life science community connected by bringing you ...
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced ... for public health agencies of all sizes. With a focus on tracking symptoms ... find appropriate health care, Mosio helps public health departments automate communications and provide ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval from the Centers ... making them the first Wharton’s jelly allografts to be assigned a Q code and ... are the first Wharton’s jelly allograft product to be recognized as a 361 HCT/P ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... (PRWEB) , ... June 29, 2020 , ... ... access to competitively procured purchasing contracts to its membership, recently named BioFit ... TIPS members with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks ...
(Date:6/28/2020)... ... ... The Indoor Lab, a leading provider of sensor solutions for monitoring foot ... ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ technology using Artificial Intelligence ... a health performance index system that scores all aspects of compliance similar to the ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... photodynamic therapy for treating cancer, today announced the company has entered a license ... The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual property ...
(Date:6/23/2020)... , ... June 23, 2020 , ... ... access to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV ... laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 ...
Breaking Biology Technology: